[1] [1] TEODORCZYK-INJEYAN J A, MCGREGOR M, TRIANO J J, et al. Elevated production of nociceptive CC chemokines and se-selectin in patients with low back pain and the effects of spinal manipulation: a nonrandomized clinical trial ［J］. The Clinical Journal of Pain, 2018, 34(1): 68-75.

[6] [6] EZZATI K, LAAKSO E L, SABERI A, et al. A comparative study of the dose-dependent effects of low level and high intensity photobiomodulation (laser) therapy on pain and electrophysiological parameters in patients with carpal tunnel syndrome ［J］. European Journal of Physical and Rehabilitation Medicine, 2020, 56(6): 733-740.

[7] [7] PIGATTO G R, SILVA C S, PARIZOTTO N A. Photobiomodulation therapy reduces acute pain and inflammation in mice ［J］Journal of Photochemistry and Photobiology B: Biology, 2019, 196: 111513.

[9] [9] VAN HELVOORT E M, DE VISSER H M, LAFEBER F, et al. IL4-10 fusion protein shows DMOAD activity in a rat osteoarthritis model ［J］. Cartilage, 2021, 13(2_suppl): 1155s-1164s.

[10] [10] ANDERS J J, ARANY P R, BAXTER G D, et al. Light-emitting diode therapy and low-level light therapy are photobiomodulation therapy ［J］. Photobiomodulation, Photomedicine, and Laser Surgery, 2019, 37(2): 63-65.

[11] [11] MENG C, XIA Q, WU H, et al. Photobiomodulation with 630?nm LED radiation inhibits the proliferation of human synoviocyte MH7A cells possibly via TRPV4/PI3K/AKT/mTOR signaling pathway ［J］. Lasers in Medical Science, 2020, 35(9): 1927-1936.

[12] [12] LI Y, WEI S, ZHANG K, et al. The inflammation and reactive oxygen species regulated by Nrf2 and NF-κB signaling pathways in 630-nm light-emitting diode irradiation treated THP-1 monocytes/macrophages ［J］. Lasers in Medical Science, 2021, 36(7): 1411-1419.

[13] [13] DELLA SANTA G M L, FERREIRA M C, MACHADO T P G, et al. Effects of photobiomodulation therapy (LED 630?nm) on muscle and nerve histomorphometry after axonotmesis ［J］. Photochemistry and Photobiology, 2021, 97(5): 1116-1122.

[15] [15] SU W, YU J, LIU Q, et al. CXCL12/CXCR4 signaling induced itch and pain sensation in a murine model of allergic contact dermatitis ［J］. Molecular Pain, 2020, 16: 1-11.

[16] [16] REAUX-LE GOAZIGO A, RIVAT C, KITABGI P, et al. Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance ［J］. European Journal Neuroscience, 2012, 36(5): 2619-2631.

[17] [17] BAI R, SHI Q, LIANG Z, et al. Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library ［J］. European Journal of Medicinal Chemistry, 2017, 126: 464-475.

[18] [18] BU H L, XIA Y Z, LIU P M, et al. The roles of chemokine CXCL13 in the development of bone cancer pain and the regulation of morphine analgesia in rats ［J］. Neuroscience, 2019, 406: 62-72.

[19] [19] ZHAO L, SONG C, HUANG Y, et al. MMP-9 regulates CX3CL1/CX3CR1 in the early phase of neuropathic pain in chronic sciatic nerve constriction injury (CCI) rats ［J］. Annals of Palliative Medicine, 2020, 9(4): 2020-2027.

[20] [20] PENG Z Y, CHEN R, FANG Z Z, et al. Increased local expressions of CX3CL1 and CCL2 are related to clinical severity in lumbar disk herniation patients with sciatic pain ［J］. Journal of Pain Research, 2017, 10: 157-165.

[21] [21] SAIKA F, KIGUCHI N, KOBAYASHI Y, et al. CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury ［J］. European Journal of Pain, 2012, 16(9): 1271-1280.

[22] [22] ZAJACZKOWSKA R, KWIATKOWSKI K, PAWLIK K, et al. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain ［J］. Pharmacological Reports, 2020, 72(5): 1310-1322.

[23] [23] JIANG L, PAN C L, WANG C Y, et al. Selective suppression of the JNK-MMP2/9 signal pathway by tetramethylpyrazine attenuates neuropathic pain in rats ［J］. Journal of Neuroinflammation, 2017, 14(1): 174.